Fierce Biotech March 8, 2024
Roche raised the curtain on its upcoming continuous glucose monitoring system featuring artificial intelligence-powered forecasts of blood sugar highs and lows.
At the International Conference on Advanced Technologies and Treatments for Diabetes, being held this week in Florence, Italy, the company put forward some initial accuracy data for its new Accu-Chek SmartGuide sensor and apps.
The real-time CGM is designed to offer AI-based glucose predictions from 30 minutes out to two hours in the future—as well as inform the user of their risk of developing hypoglycemia overnight. Roche is currently working to obtain a CE mark approval in Europe, ahead of a planned commercial rollout in select countries.
“Providing users with predictive capabilities will empower them to proactively...
Today's Sponsors
Today's Sponsor